WILMINGTON, N.C. — Alcami, a leading United States-based contract development and manufacturing organization (CDMO), announced an additional $2 million investment to expand its oral solid development and manufacturing capabilities in Wilmington, NC. The investment will add a Gerteis Mini-Pactor® roller compactor and low humidity suites to Alcami’s existing 140,000 square foot campus in Wilmington, NC. The expansion, which is on track to be completed in the first and second quarter of 2021, respectively, adds dry granulation capabilities and increased flexibility to support moisture-sensitive processes.

We are pleased to support our customers’ clinical to small scale commercial supply needs with modern, flexible, and reliable capacity,” commented Walt Kaczmarek, CEO of Alcami. “Our investment in Wilmington is another step in our continued growth strategy to become the preferred provider of drug product and analytical services in the pharmaceutical industry.”

Alcami’s cGMP oral solid manufacturing technologies are arranged in flexible suites designed for novel, advanced, and complex projects. Embedded within the manufacturing facility, in-house formulation development and analytical experts offer drug innovators co-located product development, optimization, scale-up, and life cycle management.

Facebook Comments